ApprovalTrail

Drug · DIN 02413256

M-DOCUSATE CALCIUM

No: cancelled before it was sold

Authorized, then cancelled before it was ever sold in Canada.

Status Cancelled Pre Market since April 10, 2019.
Drug Identification Number (DIN)
02413256
Company (DIN owner)
Mantra Pharma Inc.Brossard, Quebec, Canada
Schedule
Non-prescription drugs
Dosage form
Capsule
Route
Oral
Therapeutic class (ATC)
Docusate sodium A06AA02
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
DOCUSATE CALCIUM240 MG